METAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.196420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.662600E-01
Normal-vs-Stage2
2.059600E-01
Normal-vs-Stage3
4.919800E-01
Normal-vs-Stage4
4.667000E-01
Stage1-vs-Stage2
5.799600E-01
Stage1-vs-Stage3
8.754400E-01
Stage1-vs-Stage4
2.564000E-01
Stage2-vs-Stage3
4.773400E-01
Stage2-vs-Stage4
3.915000E-01
Stage3-vs-Stage4
2.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.199630E-01
Normal-vs-AfricanAmerican
6.849600E-01
Normal-vs-Asian
4.074600E-01
Caucasian-vs-AfricanAmerican
9.597200E-01
Caucasian-vs-Asian
8.907200E-01
AfricanAmerican-vs-Asian
8.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.492400E-02
Normal-vs-Female
6.571200E-01
Male-vs-Female
1.194840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.698400E-01
Normal-vs-Age(41-60Yrs)
6.299200E-01
Normal-vs-Age(61-80Yrs)
1.761710E-02
Normal-vs-Age(81-100Yrs)
9.582200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.793630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.476800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.618200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.097560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.612000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.433600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.100800E-01
Normal-vs-Daily Drinker
4.722400E-02
Normal-vs-Weekly Drinker
1.019190E-01
Normal-vs-Occasional Drinker
1.783200E-01
Normal-vs-Social Drinker
5.983400E-01
Non Drinker-vs-Daily Drinker
4.364000E-01
Non Drinker-vs-Weekly Drinker
6.206800E-01
Non Drinker-vs-Occasional Drinker
5.050500E-02
Non Drinker-vs-Social Drinker
9.938000E-01
Daily Drinker-vs-Weekly Drinker
8.331200E-01
Daily Drinker-vs-Occasional Drinker
1.378240E-02
Daily Drinker-vs-Social Drinker
4.754200E-01
Weekly Drinker-vs-Occasional Drinker
2.966200E-02
Weekly Drinker-vs-Social Drinker
6.097800E-01
Occasional Drinker-vs-Social Drinker
6.960500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.533370E-01
Normal-vs-Grade 2
5.958600E-03
Normal-vs-Grade 3
1.151580E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.446960E-04
Grade 1-vs-Grade 3
3.814500E-04
Grade 1-vs-Grade 4
1.533370E-01
Grade 2-vs-Grade 3
5.035600E-01
Grade 2-vs-Grade 4
5.958600E-03
Grade 3-vs-Grade 4
1.151580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.396200E-02
Normal-vs-NonDiabetic
1.968810E-01
Diabetic-vs-NonDiabetic
3.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.055400E-01
Normal-vs-NoPancreatitis
7.421700E-02
Pancreatitis-vs-NoPancreatitis
2.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.320600E-01
Normal-vs-N1
2.177800E-01
N0-vs-N1
8.048200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.345000E-01
Normal-vs-TP53-NonMutant
5.837600E-01
TP53-Mutant-vs-TP53-NonMutant
5.02240000033183E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
